Double baseline

Only two randomized, controlled trials have been completed, and neither provides anything like compelling data (Table 2.6). Chouinard and Albright (1997) conducted a unique evaluation of a subset of patients from a previously conducted clinical trial. Subjects were categorized and profiled at baseline and end point according to clinical severity, and a group of psychiatric nurses were asked to rate various aspects of likely outcome and quality of life to each profile (mild, moderate or severe symptoms). Health state utilities were then calculated risperidone was found to provide more than double the number of quality-adjusted life years compared with haloperidol. Csernansky and Okamoto (1999) conducted a rather more conventional trial, but included no economic analyses. However, they did find that the use of risperidone substantially reduced relapse rates compared with haloperidol—an outcome likely to have a positive impact on cost-effectiveness. 

Perhaps the greatest source of error is introduced by the double integration of the experimental derivative curve. The exact location of the baseline is critical since the outer regions or wings of the spectrum are weighted more heavily than the central portion. One necessary requirement is that the areas enclosed by the curve above and below the baseline must be equal. After the baseline and the initial and terminal points on the spectrum have been determined, the integration can be carried out rather easily by numerical techniques. 

Bergman et al., (1969) have shown that it is possible to have a sustained growth response for 30 min if the light intensity is doubled every 2 min. This was the first indication that the return of the growth rate to the baseline level after a step-up cannot simply be due to a depletion of an important metabolite. 

No definitive conclusions can be drawn concerning a possible role of rifaximin in preventing major complications of diverticular disease. Double-blind placebo-controlled trials with an adequate sample size are needed. However, such trials are difficult to perform considering the requirement of a large number of patients. Assuming a baseline risk of complications of diverticular disease of 5% per year [2], a randomized controlled trial able to detect a 50% risk reduction in complications should include 1,600 patients per treatment group considering a power of 80% (1 - (3) and an a error of 5%. 

We have spoken frequently in this chapter about sensitivity and detection limit in reference to advantages and disadvantages of the various techniques. Sensitivity and detection limit have specific definitions in atomic absorption. Sensitivity is defined as the concentration of an element that will produce an absorption of 1% (absorptivity percent transmittance of 99%). It is the smallest concentration that can be determined with a reasonable degree of precision. Detection limit is the concentration that gives a readout level that is double the electrical noise level inherent in the baseline. It is a qualitative parameter in the sense that it is the minimum concentration that can be detected, but not precisely determined, like a blip that is barely seen compared to the electrical noise on the baseline. It would tell the analyst that the element is present, but not necessarily at a precisely determinable concentration level. A comparison of detection limits for several elements for the more popular techniques is given in Table 9.2. 

Sensitivity is the concentration of analyte that will produce an absorption of 1%. Detection limit is the concentration that gives a readout level that is double the noise level in the baseline. See Table 9.2. 

As shown in Figure B2.1, double-beam spectrophotometers automatically record the true absorbance by measuring log(IR/Is), thanks to a double compartment containing two cuvettes, one filled with the solution and one filled with the solvent. Because the two cuvettes are never perfectly identical, the baseline of the instrument is first recorded (with both cuvettes filled with the solvent) and stored. Then, the solvent of the sample cuvette is replaced by the solution, and the true absorption spectrum is recorded. 

Bursters from 155-mm, M110 mustard agent projectiles are transferred by the PMD burster transfer conveyor to the burster size-reduction machine. This is a baseline-system rocket shear machine (RSM) modified to perform burster size reduction. The M6 bursters from these projectiles are cut into three equal-length sections to reduce the time required to separate/deactivate the tetrytol explosive in the COINS. From the burster size-reduction machine, the burster sections drop into the projectile component discharge hopper, through double blast gates, to the projectile component discharge chute... 

Figure 6.29 Schematic representation of the adjustment which is made to compensate for the sloping baseline in stripping voltammetry, itself due to charging of the electric double-layer at the WE.

Feeling pretty good after his long test, John and his partner agreed to repeat it two weeks later-- as part of a double blind crossover, he received physostigmine treatment instead of placebo and remained close to baseline all week while his partner got placebo and was incapacitated.. 

We found quite early that our volunteers were not placebo responders. This was apparent when we used very low doses of active drag and found no significant deviation from baseline responses. To give placebos routinely would have doubled the workload and exposed volunteers to many more hours of testing with little benefit, since the lowest doses had already been found to have little or no effect and the differences between responses to increasing doses were obvious. 

Note that, to call attention to an important source of variability in the onset time, we used the term dose onset factor (Donset). As stated, it represents the decrease in Tonso, (the time at which NF performance first falls below 25% of baseline) when the incapacitating dose (IDso) is doubled. In the case of BZ, for example, doubling the absorbed dose shortens the Tonso from four hours to less than an hour. Doubling it again presumably shortens it to just a few minutes. This would be an important concept for military plarmers to consider. Our data were insufficient to measure the Domet precisely because we preferred not to administer double doses to volunteers, hr the few cases in which actual aerosol doses were considerably higher than the intended value, however, the dramatically earlier onset of incapacitation allowed an educated guess of the Donset. 

Dysthymic Disorder. Dysthymic disorder differs from MDD by being more chronic and less severe. Yet, two issues can cloud the distinction. First, some patients experience double depression in which an episode of major depression is superimposed on dysthymia. This can make it difficult to assess treatment response when the baseline mood is dysthymia instead of a normal euthymic mood. Second, a few patients may experience a chronic major depressive episode, which, like dysthymic disorder, lasts 2 years or more. In contrast to dysthymic patients whose insidious onset of symptoms leaves them unable to say exactly when the depression started, most patients with chronic major depression can tell when their depression began. 

---